MARKER THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
MARKER THERAPEUTICS, INC. (MRKR) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 83.03 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-10
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 83.03M shares, a 78.28% increase year-over-year.
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 56.47M shares, a 22.54% increase year-over-year.
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 48.63M shares, a 6.35% increase year-over-year.
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 46.87M shares, a 2.65% increase year-over-year.
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 47.04M shares, a 3.19% increase from fiscal 2019.
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 45.59M shares, a 138.78% increase from fiscal 2018.
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 19.09M shares, a 101.96% increase from fiscal 2017.
- MARKER THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 9.45M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-06-30 | 83.03M shares 10-Q · filed 2021-08-10 | 69.82M shares 10-Q · filed 2021-08-10 | 62.71M shares derived: average of 3 quarters · filed 2021-08-10 | 58.75M shares derived: average of 4 quarters · filed 2021-08-10 | |
| 2021-03-31 | 56.47M shares 10-Q · filed 2021-05-12 | 52.55M shares derived: average of 2 quarters · filed 2021-05-12 | 50.66M shares derived: average of 3 quarters · filed 2021-05-12 | 49.64M shares derived: average of 4 quarters · filed 2021-08-10 | |
| 2020-12-31 | 48.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 47.75M shares derived: average of 2 quarters · filed 2021-03-09 | 47.36M shares derived: average of 3 quarters · filed 2021-08-10 | 47.04M shares 10-K · filed 2021-03-09 | |
| 2020-09-30 | 46.87M shares 10-Q · filed 2020-11-09 | 46.72M shares derived: average of 2 quarters · filed 2021-08-10 | 46.51M shares 10-Q · filed 2020-11-09 | 46.31M shares derived: average of 4 quarters · filed 2021-08-10 | |
| 2020-06-30 | 46.57M shares 10-Q · filed 2021-08-10 | 46.33M shares 10-Q · filed 2021-08-10 | 46.13M shares derived: average of 3 quarters · filed 2021-08-10 | 46.01M shares derived: average of 4 quarters · filed 2021-08-10 | |
| 2020-03-31 | 46.08M shares 10-Q · filed 2021-05-12 | 45.91M shares derived: average of 2 quarters · filed 2021-05-12 | 45.82M shares derived: average of 3 quarters · filed 2021-05-12 | 45.74M shares derived: average of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | 45.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 45.69M shares derived: average of 2 quarters · filed 2021-03-09 | 45.63M shares derived: average of 3 quarters · filed 2021-03-09 | 45.59M shares 10-K · filed 2021-03-09 | |
| 2019-09-30 | 45.66M shares 10-Q · filed 2020-11-09 | 45.58M shares derived: average of 2 quarters · filed 2020-11-09 | 45.54M shares 10-Q · filed 2020-11-09 | 44.19M shares derived: average of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | 45.50M shares 10-Q · filed 2020-08-10 | 45.48M shares 10-Q · filed 2020-08-10 | 43.70M shares derived: average of 3 quarters · filed 2020-08-10 | 36.21M shares derived: average of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | 45.47M shares 10-Q · filed 2020-05-11 | 42.79M shares derived: average of 2 quarters · filed 2020-05-11 | 33.11M shares derived: average of 3 quarters · filed 2020-05-11 | 27.79M shares derived: average of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | 40.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 26.93M shares derived: average of 2 quarters · filed 2020-03-12 | 21.90M shares derived: average of 3 quarters · filed 2020-03-12 | 19.09M shares 10-K · filed 2020-03-12 | |
| 2018-09-30 | 13.73M shares 10-Q · filed 2019-11-12 | 12.79M shares derived: average of 2 quarters · filed 2019-11-12 | 12.08M shares 10-Q · filed 2019-11-12 | 11.69M shares derived: average of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | 11.84M shares 10-Q · filed 2019-08-09 | 11.23M shares 10-Q · filed 2019-08-09 | 11.01M shares derived: average of 3 quarters · filed 2019-08-09 | 10.81M shares derived: average of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | 10.62M shares 10-Q · filed 2019-05-10 | 10.60M shares derived: average of 2 quarters · filed 2019-05-10 | 10.47M shares derived: average of 3 quarters · filed 2019-05-10 | 10.00M shares derived: average of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | 10.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 10.39M shares derived: average of 2 quarters · filed 2019-03-15 | 9.79M shares derived: average of 3 quarters · filed 2019-03-15 | 9.45M shares 10-K · filed 2019-03-15 | |
| 2017-09-30 | 10.22M shares 10-Q · filed 2018-11-13 | 9.40M shares derived: average of 2 quarters · filed 2018-11-13 | 9.08M shares 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | 8.58M shares 10-Q · filed 2018-08-09 | 8.50M shares 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | 8.43M shares 10-Q · filed 2018-05-15 | ||||
| 2016-03-31 | 5.88M shares 10-Q · filed 2017-05-05 | 70.59M shares 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | 43.95M shares 10-K · filed 2016-04-14 | ||||
| 2015-06-30 | 33.53M shares 10-Q/A · filed 2016-04-14 | 30.58M shares 10-Q/A · filed 2016-04-14 | 27.71M shares derived: average of 3 quarters · filed 2016-05-16 | 25.11M shares derived: average of 4 quarters · filed 2016-05-16 | |
| 2015-03-31 | 27.61M shares 10-Q · filed 2016-05-16 | 24.80M shares derived: average of 2 quarters · filed 2016-05-16 | 22.30M shares derived: average of 3 quarters · filed 2016-05-16 | 20.61M shares derived: average of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | 21.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | 19.65M shares derived: average of 2 quarters · filed 2016-04-14 | 18.27M shares derived: average of 3 quarters · filed 2016-04-14 | 15.47M shares 10-K · filed 2016-04-14 | |
| 2014-09-30 | 17.31M shares 10-Q · filed 2014-11-19 | 16.42M shares derived: average of 2 quarters · filed 2016-04-14 | 13.29M shares 10-Q · filed 2014-11-19 | 10.48M shares derived: average of 4 quarters · filed 2016-04-14 | |
| 2014-06-30 | 15.52M shares 10-Q/A · filed 2016-04-14 | 11.25M shares 10-Q/A · filed 2016-04-14 | 8.21M shares derived: average of 3 quarters · filed 2016-04-14 | 6.47M shares derived: average of 4 quarters · filed 2016-04-14 | |
| 2014-03-31 | 7.63M shares 10-Q/A · filed 2016-04-14 | 6.93M shares 10-Q/A · filed 2014-05-21 | 4.55M shares derived: average of 2 quarters · filed 2016-04-14 | 3.45M shares derived: average of 3 quarters · filed 2016-04-14 | 2.84M shares derived: average of 4 quarters · filed 2016-04-14 |
| 2013-12-31 | 1.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | 1.37M shares derived: average of 2 quarters · filed 2015-04-15 | 1.24M shares derived: average of 3 quarters · filed 2015-04-15 | 1.14M shares 10-K · filed 2015-04-15 | |
| 2013-09-30 | 1.27M shares 10-Q · filed 2014-11-19 | 1.13M shares derived: average of 2 quarters · filed 2014-11-19 | 1.03M shares 10-Q · filed 2014-11-19 | ||
| 2013-06-30 | 1.00M shares 10-Q · filed 2014-08-18 | 904.45K shares 10-Q · filed 2014-08-18 | |||
| 2013-03-31 | 806.95K shares 10-Q/A · filed 2014-05-21 | 80.69M shares 10-Q · filed 2013-05-21 | |||
| 2012-06-30 | 61.97M shares 10-Q/A · filed 2012-09-12 | 57.22M shares 10-Q/A · filed 2012-09-12 | |||
| 2012-03-31 | 52.47M shares 10-Q/A · filed 2013-08-19 | ||||
| 2011-06-30 | 46.68M shares 10-Q/A · filed 2012-09-12 | 43.64M shares 10-Q/A · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |